A key output of PGENI is targeted educational resources that lead to the development of a greater understanding of the utility of pharmacogenetics. This includes the education of public health officials, ministry of health staff, health care professionals, and the general public. PGENI is planning a series of short courses and other educational opportunities to stimulate, supplement, and update the knowledge of applied genomics, in paticular pharmacogenetics. These courses will be offered at each of the regional centers, targeting individuals involved in public health, national formulary decisions, applied genetics, medicine, pharmacy, and related disciplines.
One of the greatest obstacles to the application of new technologies is the paucity of clear examples to guide the practical implementation. PGENI will prepare Ministries of Health and other key members of public health systems in the use of applied genomics. The lessons learned from pharmacogenetics will be invaluable in the future uses of genetics to guide disease prevention and treatment.
Within PGENI there are 9 proposed regional centers. These regional centers are strategically located to provide support for all individual PGENI focus countries. It will be the regional centers responsibility to initiate and facilitate collaboration efforts with these individual countries that surround the regional center. Each regional center will have a primary investigator that will lead the areas PGENI efforts and concentrate on building collaborations in countries where none exist. With help from the individual countries, the regional centers will identify the ethnic groups within each country and obtain sample collection within those countries. Sample processing and genotyping will occur within these regional centers and will distribute the data to the individual countries and deposit them into the coordinating centers database. The regional centers will also provide an active network for the conduct of studies testing global pharmacogenetic hypotheses.